@article{3108136,
    title = "The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia",
    author = "Novakovic, T. and Martin, A.P. and Parker, M. and Ferrario, A. and Vukovic, S. and Łanda, K. and Duba, J. and Dankó, D. and Kotsopoulos, N. and Godman, B. and Ristic, J. and Stefanovic, D. and Tesic, D.",
    journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
    year = "2017",
    volume = "17",
    number = "6",
    pages = "519-521",
    publisher = "Taylor and Francis Ltd.",
    issn = "1473-7167, 1744-8379",
    doi = "10.1080/14737167.2017.1385394",
    keywords = "adult;  biomedical technology assessment;  decision making;  human;  register;  Serbia;  biomedical technology assessment;  Eastern Europe;  economics;  health care delivery;  pharmacoeconomics;  procedures;  reimbursement, Decision Making;  Delivery of Health Care;  Economics, Pharmaceutical;  Europe, Eastern;  Humans;  Reimbursement Mechanisms;  Technology Assessment, Biomedical",
    abstract = "The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry. © 2017 Informa UK Limited, trading as Taylor & Francis Group."
}